Compare Centene Corp (CNC) vs DexCom, Inc. (DXCM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Centene Corp vs DexCom, Inc. — how do they compare? Centene Corp trades at $68.55 (market cap $33.72B), while DexCom, Inc. trades at $76.3 (market cap $29.46B). The key difference: Centene Corp and DexCom, Inc. are close in size by market cap, and Centene Corp is trading nearer its 52-week high, DexCom, Inc. nearer its low. Which is the better fit depends on your goals.
| CNC | DXCM | |
|---|---|---|
Market Cap | $33.72B | $29.46B |
Sector | Health | Health |
52-Week High | $68.72 | $89.53 |
52-Week Low | $25.21 | $54.84 |
Enterprise Value | $26.35B | $28.43B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Centene Corp
Centene is a managed-care organization focused on government-sponsored healthcare plans, including Medicaid, Medicare, and the individual exchanges. Centene served 22 million medical members as of September 2021, mostly in Medicaid (68% of membership), the individual exchanges (10%), Medicare Advantage (6%), and the balance in Tricare (West region), correctional facility, and international plans. The company also serves 4 million users through the Medicare Part D pharmaceutical program.
Read more on CNC →About DexCom, Inc.
Dexcom designs and commercializes continuous glucose monitoring systems for diabetics. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to include the disposable sensor and the durable receiver.
Read more on DXCM →
